Questions with Evidence‑Based Answers and Detailed Rationales
Covering High‑Yield Drug Classes, Medication Safety, Adverse Effects,
Drug Interactions, and Emergency Antidotes for NCLEX Success.
Section 1: Anticoagulants & Antiplatelets (1–
15)
1. A patient on warfarin has an INR of 4.5 without bleeding. What
is the most appropriate action?
A. Give vitamin K 10 mg IV
B. Hold warfarin and recheck INR in 1–2 days
C. Give fresh frozen plasma
D. Increase warfarin dose
Answer: B – For INR 4.5–9 without bleeding, hold warfarin and
monitor; low‑dose oral vitamin K (1–2.5 mg) if high bleeding risk.
2. Which drug is a direct thrombin inhibitor used for stroke
prevention in atrial fibrillation?
A. Apixaban
B. Rivaroxaban
C. Dabigatran
D. Edoxaban
Answer: C – Dabigatran (Pradaxa) is a direct thrombin inhibitor;
others are factor Xa inhibitors.
,3. A patient on clopidogrel is scheduled for surgery. How many
days before surgery should it be stopped?
A. 1 day
B. 3 days
C. 5–7 days
D. 14 days
Answer: C – Clopidogrel should be stopped 5–7 days
pre‑operatively to reduce bleeding risk.
4. A patient on apixaban develops a life‑threatening bleed. Which
reversal agent is indicated?
A. Protamine sulfate
B. Vitamin K
C. Andexanet alfa
D. Idarucizumab
Answer: C – Andexanet alfa (Andexxa) reverses apixaban and
rivaroxaban.
5. A patient with HIT (heparin‑induced thrombocytopenia) has a
platelet count of 40,000. Which drug should be used instead of
heparin?
A. Warfarin
B. Argatroban
C. Enoxaparin
D. Bivalirudin (or argatroban)
Answer: D – Direct thrombin inhibitors (argatroban, bivalirudin) are
first‑line; warfarin is avoided until platelets recover.
6. A patient taking ticagrelor for acute coronary syndrome
reports dyspnea. What is the likely cause?
A. Heart failure
,B. Ticagrelor side effect (dyspnea occurs in ~14%)
C. Pulmonary embolism
D. Asthma exacerbation
Answer: B – Ticagrelor causes dyspnea via adenosine accumulation;
often self‑limiting.
7. Which antiplatelet agent irreversibly inhibits the P2Y12
receptor?
A. Aspirin
B. Ticagrelor (reversible)
C. Clopidogrel (irreversible)
D. Cangrelor (reversible)
Answer: C – Clopidogrel and prasugrel irreversibly block P2Y12;
ticagrelor and cangrelor are reversible.
8. A patient on warfarin is started on
sulfamethoxazole‑trimethoprim. What INR change is expected?
A. INR decreases
B. INR increases (TMP‑SMX inhibits warfarin metabolism)
C. No change
D. Unpredictable
Answer: B – TMP‑SMX is a strong CYP2C9 inhibitor; reduce warfarin
dose and monitor INR closely.
9. Which anticoagulant is safe to use in patients with mechanical
heart valves?
A. Dabigatran
B. Apixaban
C. Warfarin
D. Rivaroxaban
, Answer: C – Warfarin is the only approved oral anticoagulant for
mechanical valves; DOACs are contraindicated.
10. A patient on prasugrel has a history of prior stroke. Why is this
concerning?
A. Increased bleeding risk
B. Prasugrel is contraindicated in prior TIA/stroke (higher
intracranial hemorrhage)
C. No interaction
D. Decreased efficacy
Answer: B – Prasugrel is contraindicated in patients with prior
stroke/TIA due to increased ICH risk.
11. A patient receiving IV unfractionated heparin has an aPTT of
110 seconds (control 30 seconds). What action is correct?
A. Increase heparin drip rate
B. Hold heparin for 1 hour and recheck
C. Give protamine sulfate
D. No change
Answer: B – Hold heparin for 30–60 minutes; aPTT >100 seconds
increases bleeding risk.
12. Which drug is a parenteral direct thrombin inhibitor used in
HIT?
A. Enoxaparin
B. Fondaparinux
C. Bivalirudin
D. Dalteparin
Answer: C – Bivalirudin (Angiomax) and argatroban are direct
thrombin inhibitors used in HIT.